Imricor signed distribution agreement to facilitate sales in Australia and NZ

2021-04-01 02:17:50 (AET) by Ring Zhang   257


Imricor Medical Systems (ASX: IMR) signed a Distribution Agreement with Sydney-based medical device distributor Regional Health Care Group Pty Ltd (RGCH). Pursuant to the agreement, RHCG will be the exclusive distributor of Imicor's consumable products in Australia and New Zealand, and a non-exclusive distributor of Imicor's capital equipment.

Imricor Medical Systems (ASX: IMR), an ASX-listed global cardia ablation product producer, has signed a Distribution Agreement with Sydney-based medical device distributor Regional Health Care Group Pty Ltd (RGCH). Pursuant to the agreement, RHCG will be the exclusive distributor of Imicor's consumable products in Australia and New Zealand, and a non-exclusive distributor of Imicor's capital equipment.

Further to that, RHCG will also provide assistance with regulatory approvals in Australia and New Zealand for Imicor's product, with first approvals expected by year-end 2021.

Regional Health Care Group is an Australian-owned business with over 40 years of experience in the medical industry as a provider of medical consumables, contrast media, and capital equipment.

Imricor’s Chair and CEO, Steve Wedan, commented: “We are thrilled to join forces with Regional Healthcare Group to bring Imricor’s products and MRI-guided ablations to Australia and New Zealand. This is an important part of our geographical expansion plans, and we can’t think of a better partner to work with. Together, we look forward to helping improve the care of Australians and New Zealanders struggling with cardiac arrhythmias.”

RHCG General Manager Stephen Doorey added “We are extremely excited to partner with Imricor, their innovative and exciting new solution for Cardiac Ablations is a great addition to our business. RHCG has unrivalled experience in supplying and servicing medical equipment and consumables to the Radiology and Cardiology sector across Australia and New Zealand with over 1,200 devices installed.”

A bit intro about Imricor

Imicor is a leading developer of innovative MRI-compatible medical devices which are used to carry out MRI-guided cardiac catheter ablation procedures. Headquartered in the US, Imricor seeks to make a meaningful impact on patients, healthcare professionals, and healthcare facilities around the world by increasing the success rates and bringing down the overall costs of cardiac catheter ablation procedures.

The Vision-MR Ablation Catheter is the Company’s prime product offering, specifically designed to work under real-time MRI guidance, with the intent of enabling higher success rates along with a faster and safer treatment compared to conventional procedures using x-ray guided catheters.

Stock Chart

The share price of IMR moved up by 3.70% to $2.24.

text


Sources: IMR ASX Announcement


标签:

声明:这些资讯属于事实信息,仅供参考,不应被视为投资建议或用于投资决策

版权所有,转载需注明出处:61 澳洲财经资讯 news.61financial.com.au

商务合作请联系 support@61financial.com.au


61 澳洲财经资讯邮件订阅服务,每日为您推荐最新澳洲财经资讯


推广

cover
金矿公司DTM自购钻机,开始低成本后续钻探计划

维州金矿勘探公司Dart Mining NL(ASX:DTM)宣布,已在其位于维州东北部全资拥有的Granite Flat项目中开始后续钻探计划,这基于其2020年钻探活动中交汇的铜金矿化。 Dart将使用公司最近购置的Atlas Copco Diamec 262金刚石钻机来进行此次钻探活动,这将为未来的钻探计划节省大量成本并提高灵活性。

相关文章

cover
心脏消融设备公司Imricor签署其第十个iCMR实验室站点

可视化心脏消融设备公司Imricor Medical Systems,Inc.( ASX:IMR)宣布,已与德国柏林布赫Helios综合性医院(Helios Hospital Berlin-Buch)签署协议,成为第十个建立iCMR(介入性心脏磁共振成像)实验室的临床站点,将采用Imricor的产品在由MRI引导的环境下进行可视化的心脏消融手术。

cover
脱水简报- Imricor Medical Systems个股分析

Imricor Medical Systems,Inc. (ASX:IMR)是一家位于美国的医疗设备公司。该公司专注于设计,制造和销售与磁共振成像(MRI)兼容的产品,这些产品可用于治疗心律失常的心脏导管消融手术。